AngioDynamics Analyst Ratings
AngioDynamics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/05/2023 | 170.27% | HC Wainwright & Co. | $19 → $20 | Maintains | Buy |
| 09/25/2023 | 156.76% | HC Wainwright & Co. | → $19 | Initiates Coverage On | → Buy |
| 07/13/2023 | 170.27% | Canaccord Genuity | $18 → $20 | Maintains | Buy |
| 04/17/2023 | 75.68% | Raymond James | $14 → $13 | Downgrades | Strong Buy → Outperform |
| 04/03/2023 | 89.19% | Raymond James | $22 → $14 | Maintains | Strong Buy |
| 01/06/2023 | 197.3% | Raymond James | $25 → $22 | Maintains | Strong Buy |
| 10/07/2022 | 237.84% | Raymond James | $27 → $25 | Maintains | Strong Buy |
| 07/13/2022 | 264.86% | Raymond James | $32 → $27 | Maintains | Strong Buy |
| 10/15/2021 | 400% | Canaccord Genuity | $28 → $37 | Upgrades | Hold → Buy |
| 08/20/2021 | — | Oppenheimer | Initiates Coverage On | → Perform | |
| 07/14/2021 | 278.38% | Canaccord Genuity | $24 → $28 | Maintains | Hold |
| 07/09/2021 | 332.43% | Raymond James | $27 → $32 | Maintains | Strong Buy |
| 03/31/2021 | 224.32% | Canaccord Genuity | $18 → $24 | Maintains | Hold |
| 01/08/2021 | 224.32% | Raymond James | $18 → $24 | Maintains | Strong Buy |
| 11/25/2020 | 143.24% | Raymond James | → $18 | Upgrades | Market Perform → Strong Buy |
| 04/08/2020 | 89.19% | Canaccord Genuity | $18 → $14 | Maintains | Hold |
| 04/08/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 10/04/2019 | 183.78% | Keybanc | $30 → $21 | Maintains | Overweight |
| 01/07/2019 | 210.81% | Canaccord Genuity | $20 → $23 | Maintains | Hold |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/05/2023 | 170.27% | HC Wainwright公司 | $19→$20 | 维护 | 买 |
| 09/25/2023 | 156.76% | HC Wainwright公司 | →$19 | 开始承保 | →购买 |
| 07/13/2023 | 170.27% | 卡纳科特·格纳奇 | $18→$20 | 维护 | 买 |
| 04/17/2023 | 75.68% | 雷蒙德·詹姆斯 | $14→$13 | 评级下调 | 强势买入→跑赢大盘 |
| 04/03/2023 | 89.19% | 雷蒙德·詹姆斯 | $22→$14 | 维护 | 强势购买 |
| 01/06/2023 | 197.3% | 雷蒙德·詹姆斯 | $25→$22 | 维护 | 强势购买 |
| 10/07/2022 | 237.84% | 雷蒙德·詹姆斯 | $27→$25 | 维护 | 强势购买 |
| 07/13/2022 | 264.86% | 雷蒙德·詹姆斯 | $32→$27 | 维护 | 强势购买 |
| 2021年10月15日 | 400% | 卡纳科特·格纳奇 | $28→$37 | 升级 | 持有→购买 |
| 08/20/2021 | - | 奥本海默 | 开始承保 | →性能 | |
| 07/14/2021 | 278.38% | 卡纳科特·格纳奇 | $24→$28 | 维护 | 保持 |
| 07/09/2021 | 332.43% | 雷蒙德·詹姆斯 | $27→$32 | 维护 | 强势购买 |
| 03/31/2021 | 224.32% | 卡纳科特·格纳奇 | $18→$24 | 维护 | 保持 |
| 01/08/2021 | 224.32% | 雷蒙德·詹姆斯 | $18→$24 | 维护 | 强势购买 |
| 11/25/2020 | 143.24% | 雷蒙德·詹姆斯 | →$18 | 升级 | 市场表现→强劲买入 |
| 04/08/2020 | 89.19% | 卡纳科特·格纳奇 | $18→$14 | 维护 | 保持 |
| 04/08/2020 | - | KeyBanc | 评级下调 | 增持→板块权重 | |
| 2019/10/04 | 183.78% | KeyBanc | $30→$21 | 维护 | 超重 |
| 2019年07月01日 | 210.81% | 卡纳科特·格纳奇 | $20→$23 | 维护 | 保持 |
What is the target price for AngioDynamics (ANGO)?
AngioDynamics(Ango)的目标价是多少？
The latest price target for AngioDynamics (NASDAQ: ANGO) was reported by HC Wainwright & Co. on October 5, 2023. The analyst firm set a price target for $20.00 expecting ANGO to rise to within 12 months (a possible 170.27% upside). 7 analyst firms have reported ratings in the last year.
HC Wainwright&Co.于2023年10月5日报道了AngioDynamic(纳斯达克代码：ANGO)的最新目标价。这家分析公司将目标价定为20美元，预计Ango将在12个月内上涨(可能上涨170.27%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for AngioDynamics (ANGO)?
AngioDynamic(Ango)的最新分析师评级是多少？
The latest analyst rating for AngioDynamics (NASDAQ: ANGO) was provided by HC Wainwright & Co., and AngioDynamics maintained their buy rating.
对AngioDynamic(纳斯达克代码：ANGO)的最新分析师评级由HC Wainwright&Co.提供，AngioDynamic维持其买入评级。
When is the next analyst rating going to be posted or updated for AngioDynamics (ANGO)?
AngioDynamics(Ango)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AngioDynamics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AngioDynamics was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与AngioDynamic的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。AngioDynamics的上一次评级是在2023年10月5日提交的，所以你应该预计下一次评级将在2024年10月5日左右的某个时候提供。
Is the Analyst Rating AngioDynamics (ANGO) correct?
分析师对AngioDynamics(Ango)的评级正确吗？
While ratings are subjective and will change, the latest AngioDynamics (ANGO) rating was a maintained with a price target of $19.00 to $20.00. The current price AngioDynamics (ANGO) is trading at is $7.40, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的AngioDynamics(Ango)评级维持不变，目标价在19.00美元至20.00美元之间。AngioDynamics(Ango)目前的股价为7.40美元，超出了分析师的预测区间。
译文内容由第三方软件翻译。